NCT07331155 2026-03-09A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]Nanjing Leads Biolabs Co.,LtdPhase 2 Recruiting110 enrolled